Effect of study setting on anticoagulation control: a systematic review and metaregression.
about
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of SubgroupsEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequencesChallenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A ReviewPharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumonCare transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsA role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.Potentially avoidable inpatient nights among warfarin receiving patients; an audit of a single university teaching hospitalQuality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registryEvaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population.Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.Personalized medicine and atrial fibrillation: will it ever happen?Sex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up.Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesComparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics.Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US.Timing of discharge follow-up for acute pulmonary embolism: retrospective cohort study.Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVALPatient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort studyPatient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary carePercutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapyQuality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.Impact of polymorphisms of the GGCX gene on maintenance warfarin dose in Chinese populations: Systematic review and meta-analysisTrends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation.Stroke Prevention in Atrial Fibrillation: Where are We Now?Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.Monitoring of international normalized ratios: comparison of community nurses with family physicians.Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.Stroke prevention in atrial fibrillation: concepts and controversiesEffectiveness of warfarin among patients with cancerAnticoagulation control in the peri-hospitalization period.Anticoagulation in Atrial Fibrillation
P2860
Q21284803-67B89645-EAD7-404F-924F-E8E57495DAE4Q24632951-6E7F8A46-06E5-4D88-A166-EFD50995454BQ26746062-C0B79D1D-89F6-4344-88AF-62C2F045C38CQ26765949-6AF0D166-13DB-44D3-AF0C-5420A03024C2Q27006860-0908413C-9324-493C-802E-FDDD2BC1E1BFQ27025527-F29C8CEF-6F29-4BBB-A129-8608D5352DD6Q27341873-1C27CECE-A08A-41AF-B95B-FDA37D26C5C9Q28081837-F543C7A8-16F2-4A48-8AD0-B38963AF8D0EQ30996878-B3BB47CC-0782-4BF3-98B8-DE4C1D1CDB4CQ33417973-F02928CF-9446-46DE-A33B-B591541E4948Q33891646-2592DAF2-6232-4C34-AFBA-686F9B22334CQ34019616-0CAFEB34-5769-44C0-B0F4-BCD362820C14Q34029236-35C9D270-0851-47C6-A032-1710EA2C7241Q34096562-0AB2482F-2A27-4112-8F01-60B232B8C14AQ34233473-932949CD-D4EB-4B6C-AB62-06CC80A13569Q34252907-7ECFB669-6E59-4952-9E47-65EF3A64F74FQ34449234-27E5902C-907E-4FA5-8962-BA5808F4B341Q34501117-C5BDFBE0-6DBE-4315-8BBB-0CE0D5803BA5Q34557287-1222A4E4-19A2-4D13-9789-56C6BF10C028Q34585334-1AD3EF4E-AECF-435E-9A59-92B96546B769Q34622896-999E8263-19B7-4460-BB7C-EFC072006FECQ34633608-13C2B204-E8A5-4800-929C-BA1FA7A3CBC8Q34658856-2F556B0C-4DE7-4011-BB0F-69CFF70799ACQ34680367-BD388537-44AC-4EF1-AF1A-9DC4021295A6Q35017961-A7A6A1BC-FE7F-473A-A273-648E7DE724FEQ35099559-A72C2F0F-0226-434A-82CE-764380194307Q35153009-581B908D-6123-403A-A668-8A7A2AD43963Q35162449-136F8C90-7AB3-417D-B35D-618FC4C77DF0Q35214491-0D57587B-8597-47BF-A14D-0B54E4062E0AQ35629873-C848E102-B0EA-4220-B130-E7EA76BBB63EQ35757323-4B411635-1D84-4F88-902F-877CB20770F2Q35794782-FD99EB98-6FE7-4557-AC5C-EF77071D8CD9Q35811581-F9631A88-F641-42D4-8F52-310C68436B16Q35841464-F1A9B593-654B-4765-A728-1C60A25C577EQ36164026-0F58B920-1451-4126-BBA1-CBBA000FA539Q36291878-CB54324E-7CBA-4A90-9C3A-CA1A61DE7E4CQ36382375-3355884B-1452-4A4C-A009-5F4F40AD9987Q36416675-80E5695C-DD5B-4530-A872-FF373E4C0C48Q36417047-CC5AA9D1-01B4-4297-915E-32835DB0AA19Q36458782-1ECF29EE-7725-40B4-AB90-C2DB5423E247
P2860
Effect of study setting on anticoagulation control: a systematic review and metaregression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Effect of study setting on ant ...... tic review and metaregression.
@ast
Effect of study setting on ant ...... tic review and metaregression.
@en
type
label
Effect of study setting on ant ...... tic review and metaregression.
@ast
Effect of study setting on ant ...... tic review and metaregression.
@en
prefLabel
Effect of study setting on ant ...... tic review and metaregression.
@ast
Effect of study setting on ant ...... tic review and metaregression.
@en
P2093
P356
P1433
P1476
Effect of study setting on ant ...... tic review and metaregression.
@en
P2093
Alan J Forster
Alison Jennings
Dean Fergusson
Natalie Oake
P304
P356
10.1378/CHEST.129.5.1155
P407
P577
2006-05-01T00:00:00Z